Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR

Diagnostica Stago, Inc.

Parsippany, NJ, US

DIAGNOSTICA STAGO, INC. appears in FDA device records in Parsippany, NJ. FDA records list 19 510(k) clearances between and , no PMA records and one registered establishment. As of , FDA records show 42 recalls for this company, and at least one establishment registration is current.

FDA records held for this company

510(k) clearances
19
PMA records
0
Recall records
42
Registered establishments
1

510(k) clearance history

FDA records hold 19 510(k) clearances for Diagnostica Stago, Inc. between 2001 and 2026. The busiest year on record is 2001, with 5. The most recent is 2026, with 1.

Clearances by year, as a table
510(k) clearance decisions for Diagnostica Stago, Inc., by decision year
YearClearances
20015
20063
20082
20093
20101
20111
20131
20141
20161
20261
510(k) clearances on record, most recent first
K numberDeviceProduct codeDecisionDecision date
K253658STA Satellite Max®JPASubstantially Equivalent
K162227STA® - Liatest® D-DiDAPSubstantially Equivalent
K141144STA LIATEST D-DIDAPSubstantially Equivalent
K120014STA- COAG CONTROL (N+ABN) PLUSGGNSubstantially Equivalent
K111822STA(R) - LIQUID ANTI-XA, MULTI HEP CALIBRATOR, QUALITY HNF / UFH, QUALITY HBPM / LMWHKFFSubstantially Equivalent
K092937STA-HYBRID HEP CALIBRATORJITSubstantially Equivalent
K093167STA COMPACT AUTOMATED MULTI-PARAMETRIC ANALYZERJPASubstantially Equivalent
K092170STA LIATEST FREE PSGGPSubstantially Equivalent
K092113STA - FREE PS CALIBRATORJIXSubstantially Equivalent
K082248STA SATELLITE AUTOMATED MULTI-PARAMETER ANALYZERJPASubstantially Equivalent
K082675STA-R EVOLUTION AUTOMATED MULTI-PARAMETRIC ANALYZERJPASubstantially Equivalent
K061805STA - STACLOT DRVV SCREEN; STA - STACLOT DRVV CONFIRMGIRSubstantially Equivalent
K061803STA - CONTROL LA 1+2GGCSubstantially Equivalent
K053111STA-CEPHASCREEN KITGFOSubstantially Equivalent
K010455ROTACHROM HEPARIN AND STA -ROTACHROM HEPARINKFFSubstantially Equivalent
K010963STA-LIATEST FREE PROTEIN S TEST KITGGPSubstantially Equivalent
K010350STA -CALIBRATOR HBPM/LMWH KITGGNSubstantially Equivalent
K010324STA-QUALITY HBPM/LMWH KITGGNSubstantially Equivalent
K003767ASSERACHROM HPIA TEST KITLCOSubstantially Equivalent

Registered establishments

FDA registered establishments for Diagnostica Stago, Inc., with the product codes listed at each
RegistrationFEIEstablishmentAddressRegistration expiresProduct codes listed
22454512245451DIAGNOSTICA STAGO, INC.5 Century Dr, PARSIPPANY, NJ 07054 US2026and 23 more, listed in full below

Registration numbers link to the FDA registration and listing record for that establishment.

FDA product codes

Recall records

Showing 25 of 42
Device recall records naming this company, most recent first
RecallProductReasonClassificationInitiatedStatus
Z-3047-2026STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiency testA positive drift in QC values within the reagent's stated 4-hour onboard stability period was identifiedClass IIOpen, Classified
Z-1585-2026Brand Name: STA Liatest D-Di Product Name: STA Liatest D-Di Model/Catalog Number: REF 00515 Product Description: in vitro diagnostic. The STA - Liatest D-Di kit is an assay for the quantitative determination of D-dimer in venous plasma for use on STA-R, STA Compact and STA Satellite analyzers by professional laboratory personnel.After receiving customer complaints, investigations confirmed the presence of a positive bias in D-Dimer measurements throughout the entire analytical range.Class IIOpen, Classified
Z-1491-2026Brand Name: STA Liatest Free Protein S Product Name: STA Liatest Free Protein S Model/Catalog Number (REF): 00516 Product Description: The STA - Liatest Free Protein S kits are intended for use on STA-R and STA Compact for the quantitative antigenic assay of free protein S in human citrated plasma by the immuno-turbidimetric method. Component: Not ApplicableThe potential of out-of-range results and an underestimation of the free protein S level in normal patient plasmas. The defect only affects normal-range values.Class IIOpen, Classified
Z-1084-2026Asserachrom HPIA. Model/Catalog Number: 00615. The Asserachrom HPIA kit is intended for the qualitative detection in plasma or serum of the anti-heparin-platelet factor 4 (PF4) antibodies generated during the type II heparin-induced thrombocytopenia (HIT type II) by ELISA.Potential for defect for Asserachrom HPIA lot 271288, which can affect every well in the impacted strip and produce negative results.Class IIOpen, Classified
Z-0205-2026Product: STA Liatest D-Di; REF: 00515;A potential risk of underestimation of D-Dimer (D-Di) levels with the two listed lots.Class IIOpen, Classified
Z-2476-2025STA - Fibrinogen 5. Model/Catalog Number: 00674. The STA - Fibrinogen 5 kit is intended for use with the analyzers of the STA-R, STA Compact and STA Satellite families for the quantitative determination of fibrinogen levels in human citrated plasma by the clotting method of Clauss.Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.Class IIOpen, Classified
Z-2475-2025STA-Liquid Anti-Xa 8. Model/Catalog Number: 00322US. The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellite analyzers, for the quantitative determination of the plasma levels of unfractionated (UFH) and low molecular weight (LMWH) heparins by measuring their anti-Xa activity on antithrombin in a competitive assay using a synthetic chromogenic substrate.Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.Class IIOpen, Classified
Z-2474-2025STA-Liquid Anti-Xa 4. Model/Catalog Number: 00311US. The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellite analyzers, for the quantitative determination of the plasma levels of unfractionated (UFH) and low molecular weight (LMWH) heparins by measuring their anti-Xa activity on antithrombin in a competitive assay using a synthetic chromogenic substrate.Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.Class IIOpen, Classified
Z-2473-2025STA Satellite. Product Code: All references. All software versions. The STA Satellite is a fully automated benchtop analyzer capable of simultaneously performing clotting, chromogenic, and immunologic assays.Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.Class IIOpen, Classified
Z-1993-2025STA - Owren Koller. Model/Catalog Number: 00360 STA - Owren-Koller is a buffer solution intended for use as a diluent for reagents and human plasmas in coagulation tests performed with analyzers of the STA-R, STA Compact, STA Satellite and ST art families.Potential for shorter clotting times in clotting tests which have a dilution, leading to possible overestimate of around 1%Class IIOpen, Classified
Z-1577-2023STA Compact Max fully automatic clinical analyzer, Reference Numbers 58602 and 58612An internal investigation identified a bug in this firmware version, resulting in the following:Intermittent shortened coagulation times and an increased frequency of occurrence of a technical error reported by the analyzer (error 13).Class IIOpen, Classified
Z-1576-2023STA Compact Automated Multi-Parametric Analyzer, Reference Numbers 58602 and 58612An internal investigation identified a bug in this firmware version, resulting in the following:Intermittent shortened coagulation times and an increased frequency of occurrence of a technical error reported by the analyzer (error 13).Class IIOpen, Classified
Z-1575-2023STA R Max fully automatic clinical instrument designed to perform tests on human plasmas, Reference Numbers 59013 and 59026An internal investigation identified a bug in this firmware version, resulting in the following:Intermittent shortened coagulation times and an increased frequency of occurrence of a technical error reported by the analyzer (error 13).Class IIOpen, Classified
Z-1699-2020STA - Deficient VIII, Product Code: 00725. STA - Deficient VIII is an immuno-depleted human plasma intended for use in tests for the determination of factor VIII activity in plasma on STA-R and STA Compact analyzer platforms as follows: (A) STA-R Max, Product Codes: 58989, 58990 (B) STA-R Evolution, Product Codes: 58986, 58987, 58988 (C) STA Compact Max, Product Codes: 59026, 59027 (D) STA Compact, Product Codes: 58978, 58979A risk of sample-to-sample cross-contamination of Emicizumab for factor VIII assays on Stago instruments, clotting times will be shortened that may cause factor VIII levels reported to be falsely increasedClass IITerminated
Z-0738-2020STA SYSTEM CONROL N + P (ref. 00678)A positive bias was confirmed to exists on the STA - Unicalibrator levels with STA - Deficient IX and STA - Deficient VIII when compared to the International Standard (IS) for factor VIII or IX. This bias is also observed on several External Quality Assessment (EQA) results.Class IITerminated
Z-0737-2020STA UNICALIBRATOR (ref. 00675)A positive bias was confirmed to exists on the STA - Unicalibrator levels with STA - Deficient IX and STA - Deficient VIII when compared to the International Standard (IS) for factor VIII or IX. This bias is also observed on several External Quality Assessment (EQA) results.Class IITerminated
Z-0611-2019Staclot LA 20 (REF 00594) The Staclot LA and Staclot LA 20 test kits are reagent systems designed for the qualitative detection of lupus anticoagulants (LA) in plasma by the use of hexagonal HII phase phospholipid molecules (1, 2).There have been reports of shortened (T1-T2) results, where some instances of result recovery outside of the range of less than or equal to 15 seconds.Class IITerminated
Z-0610-2019Staclot LA (REF 00600) The Staclot LA and Staclot LA 20 test kits are reagent systems designed for the qualitative detection of lupus anticoagulants (LA) in plasma by the use of hexagonal HII phase phospholipid molecules (1, 2).There have been reports of shortened (T1-T2) results, where some instances of result recovery outside of the range of less than or equal to 15 seconds.Class IITerminated
Z-2994-2018Diagnostica Stago STA Noplastine CI, 10 ml vial. In-Vitro Diagnostic for determination of the prothrombin time (PT) in plasma. REF: 00666 The STA - Noplastine CI kits provide reagents for the determination of the prothrombin time (PT) in plasma with STA-R, STA Compact and STA Satellite. (In the USA this procedure has been assigned to the moderate complexity category per CLIA 1988 - CDC Analyte Code 4922; CDC Test System Codes 4677 and 4875).QC values outside of the assigned ranges (prolonged Prothrombin time / decreased PT %)Class IITerminated
Z-2993-2018Diagnostica Stago STA Noplastine CI Plus, 10 ml vial. In-Vitro Diagnostic for determination of the prothrombin time (PT) in plasma. (REF 00667) The STA - Noplastine CI Plus kits provide reagents for the determination of the prothrombin time (PT) in plasma with STA-R, STA Compact and STA Satellite. (In the USA this procedure has been assigned to the moderate complexity category per CLIA 1988 - CDC Analyte Code 4922; CDC Test System Codes 4677 and 4875).QC values outside of the assigned ranges (prolonged Prothrombin time / decreased PT %)Class IITerminated
Z-1069-2018STA - Neoplastine Cl Plus (ref. 00606) Product Usage: Manual or automated determination of the prothrombin time (PT).Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%).Class IITerminated
Z-1068-2018STA - Neoplastine Cl (ref. 00605) Product Usage: Manual or automated determination of the prothrombin time (PT).Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%).Class IITerminated
Z-1067-2018Neoplastine Cl Plus (ref. 00375) Product Usage: Manual or automated determination of the prothrombin time (PT).Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%).Class IITerminated
Z-1066-2018Neoplastine Cl Plus @ (ref.00374) Product Usage: Manual or automated determination of the prothrombin time (PT).Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%).Class IITerminated
Z-2650-2014Stago IVD, Liquid Anti-Xa, NDC 3607450003116. The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellite Analyzers for the quantitative determination of the plasma levels of unfractionated (UFH) and low molecular weight (LMWH) heparins by measuring their anti-Xa activity on antithrombin in a competitive assay using a synthetic chromogenic substrate.Diagnostica Stago Inc. received some customer complaints regarding a misreading of Reagent 1 (substrate) barcode on STA analyzers.Class IIITerminated

Verification record

There is no verification record for this company. Most companies on this site have none: a record exists only where a company asked to be verified and MDM ran the checks, so the absence of one says nothing about the company.

Where there is a record, this is where it appears: what was checked, when it was checked, and the current status. An MDM Verified badge on another website links to a verify address on this domain that resolves to this section. A badge that does not resolve here is not ours.

What MDM checks, and what it does not

MDM coverage

MDM coverage of this company lists here, newest first. Submit news.

Is this your company?

This page is built from public FDA records. Company pages are free and factual, and stay free whether or not anyone claims them. Membership never changes editorial coverage or vetting outcomes.

Claiming lets Diagnostica Stago, Inc. edit what it says about itself and list the categories it works in. It grants no badge: claiming is not verification.

Claim this page

Data as of , FDA export datePage updated Source: openFDA, public domain